Cancer Clinical Trial
— VIK-e2Official title:
VIK-e2 - Observational, Multicenter Prospective Study Evaluating Parent-child Relationship With the Setting up of a Mobile Telepresence Robot for Patients With Children Aged 15 Years or Less and Hospitalised in Long-term Protective Isolation
The intensive treatments of certain cancers and haemopathies require the implementation of a protective isolation from external micro-organisms for a period of several weeks. This isolation implies a limitation of visitors and sometimes prohibits access to young children. This raises questions concerning the maintenance of family links, and in particular the parent-child relationship as well as the psychological and emotional isolation of hospitalised patients and the resulting psychological effects.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | November 30, 2023 |
Est. primary completion date | June 24, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age= 18 - Patient with at least one child aged 15 or under - Pathology requiring a prolonged hospitalization in protective isolation - Consent dated and signed Exclusion Criteria: - Impaired cognitive functions - Performance Status -Eastern Cooperative Oncology Group (PS-ECOG) = 4 - Difficulties in speaking and understanding French - Patient under guardianship or curatorship |
Country | Name | City | State |
---|---|---|---|
France | Centre Hospitalier Lyon Sud | Lyon | |
France | Centre Leon Berard | Lyon | |
France | Institut Paoli Calmettes | Marseille |
Lead Sponsor | Collaborator |
---|---|
Centre Leon Berard |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of the use of a telepresence robot on the parent-child relationship in maintaining parenthood during parent's hospitalisation in long-term protective isolation | Observation of communications between the hospitalised patient and his/her chid(children) by a specialist in human and social sciences | Through study completion, an average of 3 months | |
Primary | Evaluation of the use of a telepresence robot on the parent-child relationship in maintaining parenthood during parent's hospitalisation in long-term protective isolation | Interview with the hospitalised patient (parent) by a specialist in human and social sciences | Through study completion, an average of 3 months | |
Secondary | Evaluation of the experience linked to the robot availability on the concerned persons (patient, children, person on charge of children) | Interview with the hospitalised patient (parent) and the person in charge of children by a specialist in human and social sciences | Through study completion, an average of 3 months | |
Secondary | Evaluation of patient's satisfaction | Interview with the hospitalised patient (parent) and the person in charge of children by a specialist in human and social sciences | Through study completion, an average of 3 months | |
Secondary | Evaluation of the impact of robot use on patient's coping strategies (adaptation and adjustment to illness and hospitalisation) | Interview with the hospitalised patient and the person in charge of children by a specialist in human and social sciences | Through study completion, an average of 3 months | |
Secondary | Evaluation of patient's experience of hospitalisation | Interview with the hospitalised patient and the person in charge of children by a specialist in human and social sciences | Through study completion, an average of 3 months | |
Secondary | Evaluation of the impact of the robot's presence at home on the children and the person in charge of the children during patient's hospitalisation | Interview with the hospitalised patient and the person in charge of children by a specialist in human and social sciences | Through study completion, an average of 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|
||
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|